Advanced HIV Re-engagement in Care
Starting soon · Not applicable
Conditions studied: Advanced HIV Disease
In brief
Adults who are hospitalized in Lusaka, Zambia, and found to have advanced HIV disease will be enrolled and randomly assigned to receive the ARC intervention or standard of care. All participants will then be followed through the end of the hospitalization and for up to 1 year after discharge from hospital.
Key facts
- Study ID
- NCT07720128
- Run by
- University of Alabama at Birmingham
- People needed
- 724
- Starts
- 2027-05-01
- Expected to finish
- 2031-08-01
- Last updated by the study team
- 2026-07-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Living with HIV
- Advanced HIV defined as CD4 <350 cells/mm3 or WHO stage 3 or 4 event
- Currently admitted to study hospital's internal medicine department
You may not qualify if…
- Planning to reside outside Lusaka after discharge
- Too sick to provide informed consent
- Known to have advanced cancer (defined as requiring chemo/radiation therapy or referred to hospice) other than Kaposi Sarcoma
- Known to have end stage kidney disease
- Known to have end stage liver disease
- No access to a telephone
- Currently incarcerated
Where it is running
- University Teaching Hospital — Lusaka, Zambia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.